← United States · Coverage record
US · SEC FORM 4
BiomX Inc.
PHGE · NYSE · CIK 0001739174 · Technology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
Insider activity timeline
No Form 4 transaction event is present in the current 180-day window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2023-05-22 · Oron Assaf.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2023-05-22 | Oron Assaf | Purchase (P) | Common Stock | 3,192 | USD 0.27 | USD 862 | SEC filing ↗ |
| 2023-05-19 | Oron Assaf | Purchase (P) | Common Stock | 6,521 | USD 0.28 | USD 1,826 | SEC filing ↗ |
| 2023-05-18 | Oron Assaf | Purchase (P) | Common Stock | 1,201 | USD 0.27 | USD 324 | SEC filing ↗ |
| 2023-02-27 | Chimovits Erez; GORDON CARL L; OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP Ltd. | Purchase (P) | Common Stock | 348,000 | USD 0.25 | USD 87,000 | SEC filing ↗ |
| 2021-07-28 | Wolfson Marina | Purchase (P) | Common Stock | 3,750 | USD 4.00 | USD 15,000 | SEC filing ↗ |
| 2021-07-28 | Sullivan Lynne Marie | Purchase (P) | Common Stock | 12,500 | USD 4.00 | USD 50,000 | SEC filing ↗ |
| 2021-07-28 | Solomon Jonathan Eitan | Purchase (P) | Common Stock | 25,000 | USD 4.00 | USD 100,000 | SEC filing ↗ |
| 2021-07-28 | SEKHRI PAUL J | Purchase (P) | Common Stock | 12,500 | USD 4.00 | USD 50,000 | SEC filing ↗ |
| 2021-07-28 | OrbiMed Israel BioFund GP Limited Partnership; OrbiMed Israel GP Ltd. | Purchase (P) | Common Stock, $0.0001 par value | 500,000 | USD — | USD — | SEC filing ↗ |
| 2021-07-28 | Moses Alan Charles | Purchase (P) | Common Stock | 5,000 | USD 4.00 | USD 20,000 | SEC filing ↗ |
| 2021-07-28 | Greig Russell | Purchase (P) | Common Stock | 3,750 | USD 4.00 | USD 15,000 | SEC filing ↗ |
| 2021-07-26 | GROSSMAN JONAS | Purchase (P) | Common Stock, par value $0.0001 | 37,500 | USD — | USD — | SEC filing ↗ |
| 2021-07-26 | GROSSMAN JONAS | Purchase (P) | Common Stock, par value $0.0001 | 37,500 | USD — | USD — | SEC filing ↗ |
| 2021-07-26 | Amusa Gbolahan | Purchase (P) | Common Stock, par value $0.0001 | 25,000 | USD — | USD — | SEC filing ↗ |
Form 4 evidence
8 transaction lines in the latest 365-day window; 115 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-03-17 | Yeganeh Reuven | Sale (S) | Common Stock, $0.0001 par value per share | 530,000 | USD 5.00 | USD 2,650,000 | SEC filing ↗ |
| 2026-03-17 | Yeganeh Reuven | C (C) | Common Stock, $0.0001 par value per share | 530,000 | USD 2.00 | USD 1,060,000 | SEC filing ↗ |
| 2026-03-16 | Yeganeh Reuven | Sale (S) | Common Stock, $0.0001 par value per share | 450,000 | USD 5.00 | USD 2,250,000 | SEC filing ↗ |
Show recent Form 4 evidence (8 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-03-17 | Yeganeh Reuven | Sale (S) | Common Stock, $0.0001 par value per share | 530,000 | USD 5.00 | USD 2,650,000 | SEC filing ↗ |
| 2026-03-17 | Yeganeh Reuven | C (C) | Common Stock, $0.0001 par value per share | 530,000 | USD 2.00 | USD 1,060,000 | SEC filing ↗ |
| 2026-03-16 | Yeganeh Reuven | Sale (S) | Common Stock, $0.0001 par value per share | 450,000 | USD 5.00 | USD 2,250,000 | SEC filing ↗ |
| 2026-03-16 | Yeganeh Reuven | C (C) | Common Stock, $0.0001 par value per share | 450,000 | USD 2.00 | USD 900,000 | SEC filing ↗ |
| 2026-03-13 | Yeganeh Reuven | Sale (S) | Common Stock, $0.0001 par value per share | 370,000 | USD 5.00 | USD 1,850,000 | SEC filing ↗ |
| 2026-03-13 | Yeganeh Reuven | C (C) | Common Stock, $0.0001 par value per share | 370,000 | USD 2.00 | USD 740,000 | SEC filing ↗ |
| 2026-03-12 | Yeganeh Reuven | Sale (S) | Common Stock, $0.0001 par value per share | 300,000 | USD 5.00 | USD 1,500,000 | SEC filing ↗ |
| 2026-03-11 | Yeganeh Reuven | C (C) | Common Stock, $0.0001 par value per share | 300,000 | USD 2.00 | USD 600,000 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-19 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | PHGE |
| CIK | 0001739174 |
| Sector | Technology |
| Industry | — Yahoo Finance |
| SEC SIC | 7372 Services-Prepackaged Software |
| Exchange | NYSE |
Data coverage
| Local Form 4 history | 115 transaction lines from 2020-06-10 to 2026-03-17 14 P purchase lines · 70 S sale lines · 31 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.